Clinical trials
Completed Metabolic Syndrome trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
760 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 4 |
| 2002 | 2 |
| 2003 | 6 |
| 2004 | 15 |
| 2005 | 12 |
| 2006 | 31 |
| 2007 | 32 |
| 2008 | 27 |
| 2009 | 33 |
| 2010 | 35 |
| 2011 | 32 |
| 2012 | 33 |
| 2013 | 39 |
| 2014 | 48 |
| 2015 | 37 |
| 2016 | 39 |
| 2017 | 50 |
| 2018 | 45 |
| 2019 | 43 |
| 2020 | 33 |
| 2021 | 46 |
| 2022 | 37 |
| 2023 | 34 |
| 2024 | 28 |
| 2025 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 760 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laval University | 12 |
| University of Copenhagen | 12 |
| University of Toronto | 9 |
| Washington University School of Medicine | 9 |
| Lund University | 8 |
| University of Aarhus | 8 |
| University of California, Davis | 8 |
| Massachusetts General Hospital | 7 |
| University of Texas at Austin | 7 |
| Wake Forest University Health Sciences | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 760 |
| Obesity | 242 |
| Insulin Resistance | 115 |
| Overweight | 77 |
| Diabetes Mellitus | 64 |
| Cardiovascular Diseases | 62 |
| Hypertension | 62 |
| Diabetes Mellitus, Type 2 | 52 |
| Inflammation | 52 |
| Weight Loss | 44 |
Trials
Showing 1 to 25 of 760. Each trial links to its page on Pharma Observatory.
660 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.